Article Information
PMID
Published By
Print ISSN
0258-851X
Online ISSN
1791-7549
History
- Received September 20, 2022
- Revision received October 2, 2022
- Accepted October 3, 2022
- Published online October 29, 2022.
Copyright & License
Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- KINGA FRITSCH1,
- GYORGY NAGY1,2,3,
- ZOLTAN SZEKANECZ4,
- GABRIELLA SZŰCS4,
- LASZLO KOVACS5 and
- TAMAS BENDER1⇑
- 1Polyclinic of Hospitaller Brothers of St. John of God, Budapest, Hungary;
- 2Department of Rheumatology, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary;
- 3Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary;
- 4Division of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary;
- 5Department of Rheumatology and Immunology, Faculty of Medicine, University of Szeged, Szeged, Hungary
- Correspondence to: Tamás Bender, MD, Ph.D., DSC, Polyclinic of Hospitaller Brothers of St. John of God, Árpád Fejedelem Street 7, H-1023 Budapest, Hungary. Tel/Fax: +36 13360266, e-mail: bender.tamas{at}irgalmas.hu, bender.tamas{at}t-online.hu






